We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SANDOZ, THREE RIVERS SHARE EXCLUSIVITY ON GENERIC REBETOL
SANDOZ, THREE RIVERS SHARE EXCLUSIVITY ON GENERIC REBETOL
April 7, 2004
The FDA has given generic drugmakers Sandoz and Three Rivers Pharmaceuticals the green light to market the first equivalent versions of Schering-Plough’s hepatitis C drug Rebetol (ribavirin) in 200-mg strength capsules, the firms said yesterday.